Zylox-Tonbridge Medical Technology acquires optimed
Zylox-Tonbridge Medical Technology agreed to acquire optimed. Reported deal value: Undisclosed. Status: Announced. Sector: Medical Technology. Target headquarters context: Ettlingen, Baden-Wuerttemberg, Germany.
This page summarizes publicly available information about the transaction as of 2026-01-16. Figures and status may change as filings and press coverage update.
Zylox - Tonbridge , a Hong Kong-listed medical technology company focused on neuro-and peripheral vascular interventional products and solutions, today annou nced that it has entered into a definitive agreement to acquire a Germany -based medical technology company , Optimed Medizinische Instrumente GmbH , specializing in research and development, production and distribution of medical devices for minimally invasive therapy worldwide, in multiple steps
Deal timeline
This transaction is classified in Medical Technology. Figures and status may change as sources update.